SNDL (SNDL) Competitors

SNDL (NASDAQ:SNDL) and Wave Life Sciences (NASDAQ:WVE) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment, valuation, dividends and community ranking.

Do insiders & institutionals believe in SNDL or WVE?

89.7% of Wave Life Sciences shares are held by institutional investors. 29.1% of Wave Life Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Which has more volatility & risk, SNDL or WVE?

SNDL has a beta of 3.39, indicating that its stock price is 239% more volatile than the S&P 500. Comparatively, Wave Life Sciences has a beta of -1.04, indicating that its stock price is 204% less volatile than the S&P 500.

Does the MarketBeat Community believe in SNDL or WVE?

Wave Life Sciences received 225 more outperform votes than SNDL when rated by MarketBeat users. However, 71.94% of users gave SNDL an outperform vote while only 67.78% of users gave Wave Life Sciences an outperform vote.

Company	Underperform	Outperform
SNDL	Outperform Votes 141 71.94%	Underperform Votes 55 28.06%
Wave Life Sciences	Outperform Votes 366 67.78%	Underperform Votes 174 32.22%

Which has higher valuation & earnings, SNDL or WVE?

Wave Life Sciences has lower revenue, but higher earnings than SNDL. Wave Life Sciences is trading at a lower price-to-earnings ratio than SNDL, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SNDL	$920.45M	0.43	-$127.91M	-$0.26	-5.77
Wave Life Sciences	$108.30M	12.77	-$57.51M	-$0.79	-11.41

Do analysts prefer SNDL or WVE?

SNDL presently has a consensus price target of $3.63, indicating a potential upside of 141.67%. Wave Life Sciences has a consensus price target of $22.60, indicating a potential upside of 150.83%. Given Wave Life Sciences' higher possible upside, analysts clearly believe Wave Life Sciences is more favorable than SNDL.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SNDL	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Wave Life Sciences	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	3.00

Is SNDL or WVE more profitable?

SNDL has a net margin of -12.11% compared to Wave Life Sciences' net margin of -66.50%. SNDL's return on equity of -8.27% beat Wave Life Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SNDL	-12.11%	-8.27%	-6.96%
Wave Life Sciences	-66.50%	-280.57%	-52.90%

Does the media refer more to SNDL or WVE?

In the previous week, Wave Life Sciences had 14 more articles in the media than SNDL. MarketBeat recorded 23 mentions for Wave Life Sciences and 9 mentions for SNDL. Wave Life Sciences' average media sentiment score of 0.83 beat SNDL's score of 0.33 indicating that Wave Life Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SNDL	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Wave Life Sciences	11 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Wave Life Sciences beats SNDL on 10 of the 18 factors compared between the two stocks.